Roche tops estimates with H1 sales at 30.71B Swiss francs

Donnerstag, 22. Juli 2021 07:03

F. Hoffmann-La Roche AG revealed on Thursday that its sales in the first fiscal half grew 8% compared to the same period the year prior, coming in at 30.71 billion Swiss francs, surpassing the expectations.

The company's pharmaceutical division observed a 3% yearly decline in sales during the first six-month period in 2021. On the other hand, sales in the diagnostics division soared 51% compared to the first half of fiscal 2020.

The company's net income amounted to 8.2 billion Swiss francs, 2% higher than the previous year's first half. Its core earnings per share climbed 6% on a yearly basis, to reach 10.56 Swiss francs.

Kapcsolódó linkek: Roche Holding
Breaking the News / BU